HYPERBARICS (HBOT) AND COVID 19
Studies have shown that lung damage caused by COVID can be healed in as little as 10 sixty minute sessions!
One potential benefit of HBOT for COVID-19 is that it can improve oxygenation in the body. As COVID-19 primarily affects the respiratory system, individuals with severe cases of the illness may have difficulty breathing and require supplemental oxygen. HBOT can help to increase the levels of oxygen in the body, which can improve respiratory function and reduce the risk of complications.
Additionally, HBOT has been shown to have anti-inflammatory effects, which can help to reduce the cytokine storm associated with severe cases of COVID-19. Cytokines are signaling molecules that play a role in the body's immune response. In some individuals with COVID-19, the immune system overreacts, leading to a cytokine storm that can cause damage to the body's tissues. HBOT can help to reduce inflammation and modulate the immune system, which may help to prevent a cytokine storm.
There is limited research on the use of HBOT for COVID-19, and further studies are needed to fully understand the potential benefits of this therapy. However, based on existing research and clinical experience, HBOT may be a useful adjunctive therapy for individuals with severe cases of COVID-19.
In conclusion, hyperbaric oxygen therapy has potential benefits for individuals with COVID-19 by improving oxygenation and reducing inflammation. It may be a useful adjunctive therapy for those with severe cases of the illness.